You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
Two more contenders have stepped into the ring in the fight for inhalable insulin. Eli Lilly and Company and Dura Pharmaceuticals, a supplier for respiratory conditions, are financially uniting efforts to achieve inhalable insulin. Using an undisclosed sum from Lilly, Dura will try to suit its technology for a dry powder inhaler (DPI) for use with insulin.
Dura spokesperson Greg Mann emphasized that this announcement represents only a collaboration, and the companies "have not disclosed any information pertaining to development stages."
When Dura began developing the DPI, the idea was that people with asthma could use it as an inhaler. The DPI has several advantages over current inhalers: it contains no CFCs (chlorofluorocarbons); no powdered medication gets trapped in the mouth, as a motor blows it efficiently into the lungs; and people with trouble breathing can still get a full dose, because the motor does the inhaling for them.
After getting the FDA to approve its DPI, Dura's next job is to figure out how to get insulin into a powder form. Eventually, once the technology is ready, Lilly will conduct clinical trials.
Two other companies are already conducting clinical trials as part of the FDA approval process. Inhale Therapeutic Systems of San Carlos, California, in cooperation with Pfizer, has built a device that uses air compression to push powdered insulin into the lungs. Aradigm Corp. of Hayward, California, in conjunction with Novo Nordisk Pharmaceuticals, is developing a battery-operated system that works with liquid aerosol insulin.
Categories: Asthma, Insulin, Novo Nordisk
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...